Jump to content

Gilead begins testing inhalable form of remdisivir


UncleSam

Recommended Posts

https://www.reuters.com/article/us-health-coronavirus-gilead-remdesivir/gilead-begins-testing-inhalable-form-of-remdisivir-for-covid-19-idUSKBN2492WU

Gilead begins testing inhalable form of remdisivir for COVID-19

(Reuters) - Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals.

The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization.

The drug is currently used intravenously and an inhaled formulation would be given through a nebulizer, which could potentially allow for easier administration outside hospitals.

Remdesivir was granted emergency use authorization in the United States to treat severe cases of COVID-19 in patients who are hospitalized.

Gilead is hoping to target the disease at the onset with the inhaled form of remdesivir, by delivering the drug directly to the primary site of infection.

Remdesivir is believed to be at the forefront in the fight against the coronavirus after the drug helped shorten hospital recovery times in a clinical trial.

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...